학술논문
Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis
Document Type
Article
Author
Source
In: Pediatric Blood and Cancer . (Pediatric Blood and Cancer, May 2014, 61(5):879-884)
Subject
Language
English
ISSN
15455017
15455009
15455009